Stock KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Kiniksa Pharmaceuticals International, plc

Equities

KNSA

GB00BRXB0C07

Delayed Nasdaq
Other stock markets
 18:00:00 03/07/2024 BST 		5-day change 1st Jan Change
19.1 USD +3.52% Intraday chart for Kiniksa Pharmaceuticals International, plc +3.08% +8.89%
07-01 Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf MT
07-01 Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) dropped from Russell Microcap Value Index CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis
AQ
Kiniksa Pharmaceuticals Sponsors American Heart Association s Addressing Recurrent Pericarditis Initiative
AQ
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
AQ
Kiniksa Pharmaceuticals : Investor Presentation
PU
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
AQ
Sector Spotlight: Orphan Drug Developers With Significant Upside
AQ
Analysts Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL)
AQ
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
AQ
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
AQ
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
AQ
PRACTICE STATEMENT LETTER PROPOSED SCHEME OF ARRANGEMENT IN RESPECT OF: KINIKSA PHARMACEUTICALS, LTD - Form 8-K
PU
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
AQ
Kiniksa Pharmaceuticals Provides Corporate Update
AQ
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
AQ
Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
AQ
Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KNSA Stock
  4. News Kiniksa Pharmaceuticals International, plc
  5. Press Releases